chr19-36183496-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_152477.5(ZNF565):c.470G>A(p.Arg157His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_152477.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF565 | NM_152477.5 | c.470G>A | p.Arg157His | missense_variant | 5/5 | ENST00000304116.10 | NP_689690.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF565 | ENST00000304116.10 | c.470G>A | p.Arg157His | missense_variant | 5/5 | 2 | NM_152477.5 | ENSP00000306869.5 | ||
ZNF565 | ENST00000591473.1 | c.275G>A | p.Arg92His | missense_variant | 4/4 | 1 | ENSP00000465906.1 | |||
ZNF565 | ENST00000355114.9 | c.590G>A | p.Arg197His | missense_variant | 5/5 | 2 | ENSP00000347234.5 | |||
ZNF565 | ENST00000392173.6 | c.470G>A | p.Arg157His | missense_variant | 5/5 | 2 | ENSP00000376013.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251474Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135912
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461894Hom.: 0 Cov.: 33 AF XY: 0.0000261 AC XY: 19AN XY: 727248
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 30 AF XY: 0.0000269 AC XY: 2AN XY: 74342
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at